Mechanism of the protective effect of intraperitoneally administered agonists for formyl peptide receptors against chemotherapy-induced alopecia

Bioscience, Biotechnology and Biochemistry

Volumn 71, Issue 5, 2007, Pages 1198-1202

  Tsuruki, Takahiro ^a   Takahata, Kyoya ^b   Yoshikawa, Masaaki ^a  

^a KYOTO UNIVERSITY   (Japan)

^b Yamawaki Gakuen Junior College   (Japan)

Author keywords

Alopecia; Etoposide; Formyl peptide receptor like 1 (FPRL1); Interleukin 1; Nuclear factor B (NF B)

Indexed keywords

AMINO ACIDS; CHEMOTHERAPY; ENZYME INHIBITION; RATS;

ALOPECIA; ETOPOSIDES; FORMYL PEPTIDE RECEPTOR-LIKE 1 (FPRL1); INTERLEUKIN-1; NUCLEAR FACTORS;

PEPTIDES;

RATTUS;

ETOPOSIDE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; FORMYLPEPTIDE RECEPTOR; MMK 1 PEPTIDE; MMK-1 PEPTIDE; PEPTIDE; UNCLASSIFIED DRUG;

ALOPECIA; ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DRUG POTENTIATION; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; RAT; SPRAGUE DAWLEY RAT;

ALOPECIA; ANIMALS; ETOPOSIDE; FEMALE; INJECTIONS, INTRAPERITONEAL; MALE; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; PEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, FORMYL PEPTIDE;

EID: 34347392969     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.60656     Document Type: Article

References (18)

1. Tsuruki, T., Takahata, K., and Yoshikawa, M., A soy-derived immunostimulating peptide inhibits etoposide-induced alopecia in neonatal rats. J. Invest. Dermatol., 122, 848-850 (2004).
2. Tsuruki, T., Ito, A., Takahata, K., and Yoshikawa, M., FPRL1 receptor agonist peptides prevent etoposide-induced alopecia in neonatal rats. J. Invest. Dermatol., 123, 242-243 (2004).
3. Murphy, P. M., Ozcelik, T., Kenney, R. T., Tiffany, H. L., McDermott, D., and Francke, U., A structural homologue of the N-formyl peptide receptor; characterization and chromosome mapping of a peptide chemoattractant receptor family. J. Biol. Chem., 267, 7637-7643 (1992).
4. Gao, J. L., Becker, E. L., Freer, R. J., Muthukumaraswamy, N., and Murphy, P. M., A high potency nonformylated peptide agonist for the phagocyte N-formylpeptide chemotactic receptor. J. Exp. Med., 180, 2191-2197 (1994).
5. Bae, Y. S., Lee, H. Y., Jo, E. J., Kim, J. I., Kang, H. K., Ye, R. D., Kwak, J. Y., and Ryu, S. H., Identification of peptides that antagonize formyl peptide receptor-like 1-mediated signaling. J. Immunol., 173, 607-614 (2004).
6. Shin, E. H., Lee, H. Y., Kim, S. D., Jo, S. H., Kim, M. K., Park, K. S., Lee, H., and Bae, Y. S., Trp-Arg-Trp-Trp-Trp-Trp antagonizes formyl peptide receptor like 2-mediated signaling. Biochem. Biophys. Res. Commun., 341, 1317-1322 (2006).
7. La, M., D'Amico, M., Bandiera, S., Di Filippo, C., Oliani, S. M., Gavins, F. N., Flower, R. J., and Perretti, M., Annexin 1 peptides protect against experimental myocardial ischemia-reperfusion: analysis of their mechanism of action. FASEB J., 15, 2247-2256 (2001).
8. Klein, C., Paul, J. I., Sauve, K., Schmidt, M. M., Arcangeli, L., Ransom, J., Trueheart, J., Manfredi, J. P., Broach, J. R., and Murphy, A. J., Identification of surrogate agonists for the human FPRL-1 receptor by autocrine selection in yeast. Nat. Biotechnol., 16, 1334-1337 (1998).
9. Hu, J. Y., Le, Y., Gong, W., Dunlop, N. M., Gao, J. L., Murphy, P. M., and Wang, J. M., Synthetic peptide MMK-1 is a highly specific chemotactic agonist for leukocyte FPRL1. J. Leukoc. Biol., 70, 155-161 (2001).
10. Hussein, A. M., Interleukin 1 protects against 1-β-D- arabinofuranosylcytosine-induced alopecia in the newborn rat animal model. Cancer Res., 51, 3329-3330 (1991).
11. Arbour, N., Tremblay, P., and Oth, D., N-formyl-methionyl-leucyl- phenylalanine induces and modulates IL-1 and IL-6 in human PBMC. Cytokine, 8, 468-475 (1996).
12. Ferreira, S. H., Lorenzetti, B. B., Bristow, A. F., and Poole, S., Interleukin-1β as a potent hyperalgesic agent antagonized by a tripeptide analogue. Nature, 334, 698-700 (1988).
13. Baeuerle, P. A., and Henkel, T., Function and activation of NF-κB in the immune system. Annu. Rev. Immunol., 12, 141-179 (1994).
14. Liu, S. F., Ye, X., and Malik, A. B., Pyrrolidine dithiocarbamate prevents I-κB degradation and reduces microvascular injury induced by lipopolysaccharide in multiple organs. Mol. Pharmacol., 55, 658-667 (1999).
15. Hook, W. A., Schiffmann, E., Aswanikumar, S., and Siraganian, R. P., Histamine release by chemotactic, formyl methionine-containing peptides. J. Immunol., 117, 594-596 (1976).
16. Okamoto, H., and Nakano, K., Regulation of interleukin-1 synthesis by histamine produced by mouse peritoneal macrophages per se. Immunology, 69, 162-165 (1990).
17. Ninomiya-Tsuji, J., Kishimoto, K., Hiyama, A., Inoue, J., Cao, Z., and Matsumoto, K., The kinase Tak1 can activate the NIK-IκB as well as the MAP kinase cascade in the IL-1 signaling pathway. Nature, 398, 252-256 (1999).
18. Tsuruki, T., and Yoshikawa, M., Orally administered FPRL1 receptor agonist peptide MMK-1 inhibits etoposide-induced alopecia by a mechanism different from intraperitoneally administered MMK-1. Peptides, 27, 820-825 (2006).